Cytokine Expression Mechanism of Action in Inflammation and Role of MAPK Kinase 6 in Arthritis: Distinct

Development of p38 (cid:1) inhibitors for rheumatoid arthritis has been hindered by toxicity and limited efficacy. Therefore, we evaluated whether MKK6, an upstream kinase that regulates multiple p38 isoforms, might be an alternative therapeutic target in inflammatory arthritis. Wild-type (WT), MKK6 (cid:2) / (cid:2) , and MKK3 (cid:2) / (cid:2) mice were administered K/B (cid:3) N serum to induce arthritis. Articular expression of activated kinases and cytokines was determined by Western blot, qPCR, ELISA, and multiplex analysis. Immunoprecipitation and confocal microscopy experiments were performed to determine the subcellular location of MKK6, P-p38, and MAPKAPK2 (MK2). Arthritis scores were significantly lower in MKK6 (cid:2) / (cid:2) mice compared with WT mice. Joint destruction and osteoclast differentiation were lower in MKK6 (cid:2) / (cid:2) , as were articular IL-6 and matrix metalloproteinase-3 expression. Phospho-p38 levels were modestly decreased in the joints of arthritic MKK6 (cid:2) / (cid:2) mice compared with WT but were significantly higher than MKK3 (cid:2) / (cid:2) mice. P-MK2 was low in MKK6 (cid:2) / (cid:2) and MKK3 (cid:2) / (cid:2) mice. Uncoupled p38 and MK2 activation was also observed in cultured, MKK6 (cid:2) / (cid:2) FLS and confirmed using kinase assays. Immunoprecipitation assays and confocal microscopy showed that P-p38 and MK2 colocalized in activated WT but not MKK6 (cid:2) / (cid:2) FLS. Distinct patterns of cytokine production were observed in MKK6 (cid:2) / (cid:2) and MKK3 (cid:2) / (cid:2) cells. MKK6 deficiency suppresses inflammatory arthritis and joint destruction, suggesting it might be a therapeutic target for inflammation. Although MKK3 and MKK6 activate the p38 pathway, they regulate distinct subsets of proinflammatory cytokines. MKK6 appears mainly to facilitate p38 and MK2 colocalization in the nucleus rather than to phosphorylate p38. The Journal of Immunology, 2009, 183: 1360–1367. These data show that MKK6 and MKK3 regulate distinct cytokine profiles.

[1]  T. Cheng,et al.  Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[2]  K. Asadullah,et al.  Protein kinases as small molecule inhibitor targets in inflammation. , 2007, Current medicinal chemistry.

[3]  G. Firestein,et al.  Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes , 2007, Arthritis research & therapy.

[4]  Bennett T. Farmer,et al.  Molecular basis of MAPK-activated protein kinase 2:p38 assembly , 2007, Proceedings of the National Academy of Sciences.

[5]  C. Lepre,et al.  Crystal Structure of the P38α-MAPKAP Kinase 2 Heterodimer* , 2007, Journal of Biological Chemistry.

[6]  P. Blackshear,et al.  Regulation of Suppressor of Cytokine Signaling 3 (SOCS3) mRNA Stability by TNF-α Involves Activation of the MKK6/p38MAPK/MK2 Cascade1 , 2007, The Journal of Immunology.

[7]  H. Niu,et al.  MAPK-activated Protein Kinase-2 (MK2)-mediated Formation and Phosphorylation-regulated Dissociation of the Signal Complex Consisting of p38, MK2, Akt, and Hsp27* , 2006, Journal of Biological Chemistry.

[8]  F. Pucino,et al.  Use of biologics in rheumatoid arthritis: where are we going? , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[9]  R. Flavell,et al.  Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Matthew Brook,et al.  Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Regulates Tumor Necrosis Factor mRNA Stability and Translation Mainly by Altering Tristetraprolin Expression, Stability, and Binding to Adenine/Uridine-Rich Element , 2006, Molecular and Cellular Biology.

[11]  H. Okamoto.  Tumor necrosis factor inhibitors for rheumatoid arthritis. , 2006, The New England journal of medicine.

[12]  H. Osada,et al.  p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression. , 2005, Biochemical and biophysical research communications.

[13]  D. Green,et al.  Regulation of arthritis by p53: critical role of adaptive immunity. , 2005, Arthritis and rheumatism.

[14]  D. Ganem,et al.  The Kaposin B Protein of KSHV Activates the p38/MK2 Pathway and Stabilizes Cytokine mRNAs , 2005, Science.

[15]  M. V. van Leeuwen,et al.  Strong inhibition of TNF-α production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor , 2004, Arthritis research & therapy.

[16]  G. Firestein,et al.  Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis. , 2004, The American journal of pathology.

[17]  W. Bugbee,et al.  Quantitative biomarker analysis of synovial gene expression by real-time PCR , 2003, Arthritis research & therapy.

[18]  H. Yoshikawa,et al.  Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. , 2003, Arthritis and rheumatism.

[19]  J. Boehm,et al.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.

[20]  Nobuyuki Tanaka,et al.  Mechanism of p38 MAP kinase activation in vivo. , 2003, Genes & development.

[21]  M. Fitzgibbon,et al.  Structure of Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinase 2 Suggests a Bifunctional Switch That Couples Kinase Activation with Nuclear Export* , 2002, The Journal of Biological Chemistry.

[22]  Jiahuai Han,et al.  Activation of p38α MAPK Enhances Collagenase-1 (Matrix Metalloproteinase (MMP)-1) and Stromelysin-1 (MMP-3) Expression by mRNA Stabilization* , 2002, The Journal of Biological Chemistry.

[23]  G. Kollias,et al.  MK2 Targets AU-rich Elements and Regulates Biosynthesis of Tumor Necrosis Factor and Interleukin-6 Independently at Different Post-transcriptional Levels* , 2002, The Journal of Biological Chemistry.

[24]  Qingbo Xu,et al.  Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[25]  J. Boehm,et al.  Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. , 2000, Arthritis and rheumatism.

[26]  V. Kouskoff,et al.  The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis. , 1999, Arthritis and rheumatism.

[27]  Klaus Resch,et al.  The p38 MAP kinase pathway signals for cytokine‐induced mRNA stabilization via MAP kinase‐activated protein kinase 2 and an AU‐rich region‐targeted mechanism , 1999, The EMBO journal.

[28]  M. Gaestel,et al.  MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis , 1999, Nature Cell Biology.

[29]  R. Flavell,et al.  Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Bröcker,et al.  The MKK6/p38 Stress Kinase Cascade Is Critical for Tumor Necrosis Factor-–Induced Expression of Monocyte-Chemoattractant Protein-1 in Endothelial Cells , 1999 .

[31]  D. Johnson,et al.  Purification and activation of recombinant p38 isoforms alpha, beta, gamma, and delta. , 1998, Protein expression and purification.

[32]  C. Marshall,et al.  Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2 , 1998, Current Biology.

[33]  M. Gaestel,et al.  Leptomycin B‐sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation , 1998, The EMBO journal.

[34]  Roger J. Davis,et al.  Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6* , 1998, The Journal of Biological Chemistry.

[35]  F. Posas,et al.  Osmotic activation of the HOG MAPK pathway via Ste11p MAPKKK: scaffold role of Pbs2p MAPKK. , 1997, Science.

[36]  G. Firestein,et al.  Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha. , 1991, Journal of immunology.